Dose-finding Study of Selective Serotonin Reuptake Inhibitors to Enhance Neuroplasticity

NCT04221256 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Closure due to COVID-19 pandemic

Conditions

Stroke, Ischemic

Interventions

DRUG: Administration of SSRI escitalopram
BEHAVIORAL: Paired Associative stimulation
DRUG: Administration of Placebo

Sponsor

Burke Medical Research Institute